SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-041124
Filing Date
2023-11-14
Accepted
2023-11-14 16:16:13
Documents
90
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1191644
2 ex31-1.htm EX-31.1 17940
3 ex31-2.htm EX-31.2 17946
4 ex32-1.htm EX-32.1 6878
5 ex32-2.htm EX-32.2 6786
  Complete submission text file 0001493152-23-041124.txt   7124738

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE eltp-20230930.xsd EX-101.SCH 56387
7 XBRL CALCULATION FILE eltp-20230930_cal.xml EX-101.CAL 78195
8 XBRL DEFINITION FILE eltp-20230930_def.xml EX-101.DEF 225750
9 XBRL LABEL FILE eltp-20230930_lab.xml EX-101.LAB 470430
10 XBRL PRESENTATION FILE eltp-20230930_pre.xml EX-101.PRE 389510
84 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1116738
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-15697 | Film No.: 231406509
SIC: 2834 Pharmaceutical Preparations